Food and Drug Administration (2023) Examining off-label prescribing of Ozempic for weight loss, Qeios (2023) Wegovy (semaglutide): a new weight loss drug for chronic weight management, Journal of Investigative Medicine (2022) Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): A 56-week, open-label, randomized clinical trial, Diabetes Care (2018) Clinical insight on semaglutide for chronic weight management in adults: patient selection and special considerations, Drug Design, Development and Therapy (2022) Semaglutide, MedlinePlus (2023) Clinical insight on semaglutide for chronic weight management in adults: Patient selection and special considerations, Drug Design, Development and Therapy (2022) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Physician consultation before use remains paramount
Intermediate time points (e.g., 4, 8, 16, or 20 weeks) were not reported in the published summaries reviewed
As a ghrelin receptor agonist, it also increases hunger
Its commonly used by athletes looking to improve muscle growth and recovery, individuals seeking to lose fat, and those looking to improve their skin health
Pain during gripping activities, weakness in the affected arm, and decreased function can persist for months or even years
